A recent study reveals that patients who stop using popular slimming jabs like Wegovy and Mounjaro may regain shed pounds far faster than those who halt conventional lifestyle regimens.
Research printed in a leading health publication points out that while overweight individuals often shed about a fifth of their body weight while on the medication, the mass returns at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing such medications must be aware of the risk of quick rebound weight gain when the treatment ends," warns expert Dr. Susan Jebb.
That rate of recovery means a reversion to original mass in about a year and a half.
Analyzing Therapies
The research, which reviewed dozens of trials involving thousands of participants, compared the results of GLP-1 agonists with older methods.
Scientists point out that individuals who lose weight through lifestyle changes alone typically see a less rapid creep back—approximately 100 grams monthly—post-intervention.
Explaining the Fast Rebound
Nutrition scientists suggest the way of the injections accounts for the amplified regain.
The injections copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the system to produce less of its own natural hormone, and could diminish responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication results in appetite is uncontrolled, making overeating much more probable."
A Chronic Disease?
Medical guidelines advise the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.
Professionals argue that, due to the significant potential of relapse, the treatment should be considered life-long.
This opinion is reinforced by drug manufacturers, who note that the results "highlight the persistent character of obesity," comparing it to managing diseases like high blood pressure.
Patient Experiences
Individuals who have come off the jabs explain a sudden resurgence of cravings.
"It was like a switch that goes on and you're instantly starving," described an individual.
This difficulty is compounded if patients have not established sustainable dietary or behavioural modifications during treatment.
Widespread Interest
Recent estimates suggest that millions of people in the UK have used these injections in the past year, with demand remaining high.
- Use is more common among females than men.
- The middle-aged demographic shows the highest level of interest.
- A large proportion access the medications through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while the jabs are powerful agents for weight loss, they are not a standalone solution and maintained weight loss relies on integrated lifestyle management.
